JPT

JPT offers a large portfolio of peptide products and services supporting all development phases of new cell therapies and vaccines. These products range from discovery tools for epitope and target identification, to various peptide formats for immune monitoring and clinical grade peptides to support clinical vaccination and cell therapy trials... JPT has developed a variety of unique peptide-based products allowing systematic evaluation of cellular and humoral immunity. In addition to peptide formats allowing T-cell and B-cell epitope discovery, antigen-specific T-cell stimulation and immune monitoring our clinical grade products support clinical trials for the development of new immunotherapeutics and vaccines... Since 2004, JPT has maintained an active quality management system that is reviewed, audited and certified annually by an independent certification body (TÜV Rheinland) to ISO 9001 standards. This includes full process documentation and an early warning system in case of..

Also known as: JPT and Facebook Ireland Ltd., JPT Peptide Technolgies, JPT Peptide Technolgies GmbH, JPT Peptide Technologies, JPT Peptide Technologies GmbH, JPT Peptide Technologies Inc.

Registration numbers: HRB 92692 (W)

VAT numbers: DE814044483

Primary location: Kensington United States